| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biomedical and Environmental Health Sciences, School of Public Health, University of California, Berkeley, California 94720
Benzene, an important industrial chemical, is myelotoxic and leukemogenic in humans. It is metabolized by cytochrome P450 2E1 to various phenolic metabolites which accumulate in the bone marrow. Bone marrow contains high levels of myeloperoxidase which can catalyze the further metabolism of the phenolic metabolites to reactive free radical species. Redox cycling of these free radical species produces active oxygen. This active oxygen may damage cellular DNA (known as oxidative DNA damage) and induce genotoxic effects. Here we report the induction of oxidative DNA damage by benzene and its phenolic metabolites in HL60 cells in vitro and in the bone marrow of C57BL/6 x C3H F1 mice in vivo utilizing 8-hydroxy-2'-deoxyguanosine as a marker. HL60 cells (a human leukemia cell line) contain high levels of myeloperoxidase and were used as an in vitro model system. Exposure of these cells to phenol, hydroquinone, and 1,2,4-benzenetriol resulted in an increased level of oxidative DNA damage. An increase in oxidative DNA damage was also observed in the mouse bone marrow in vivo 1 h after benzene administration. A dose of 200 mg/kg benzene produced a 5-fold increase in the 8-hydroxydeoxyguanosine level. Combinations of phenol, catechol, and hydroquinone also resulted in significant increases in steady state levels of oxidative DNA damage in the mouse bone marrow but were not effective when administered individually. Administration of 1,2,4-benzenetriol alone did, however, result in a significant increase in oxidative DNA damage. This represents the first direct demonstration of active oxygen production by benzene and its phenolic metabolites in vivo. The conversion of benzene to phenolic metabolites and the subsequent production of oxidative DNA damage may therefore play a role in the benzene-induced genotoxicity, myelotoxicity, and leukemia.
1 Supported by Grants P42ES04705 and P30ES01896 from the National Institute of Environmental Health Sciences. P. K. and K. B. M. are trainees of the Health Effects Component of the UC Toxic Substances Program. L. Z. is supported by the William and Ada Isabell Steel Memorial Graduate Scholarship from Simon Fraser University, Burnaby, British Columbia, Canada.
2 Present address: Department of Drug Metabolism and Pharmacokinetics, American Cyanamid Company, Pearl River, NY 10965.
3 Permanent address: Bioenergetic Research Laboratory, Faculty of Applied Science, Simon Fraser University, Burnaby, British Columbia, Canada V5A 1S6.
4 To whom requests for reprints should be addressed, at Department of Biomedical and Environmental Health Sciences, School of Public Health, 322-Warren Hall, University of California, Berkeley, CA 94720.
Received 9/24/92. Accepted 12/22/92.
This article has been cited by other articles:
![]() |
M. Shen, Q. Lan, L. Zhang, S. Chanock, G. Li, R. Vermeulen, S. M. Rappaport, W. Guo, R. B. Hayes, M. Linet, et al. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity Carcinogenesis, October 1, 2006; 27(10): 2083 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Winn Homologous Recombination Initiated by Benzene Metabolites: A Potential Role of Oxidative Stress Toxicol. Sci., March 1, 2003; 72(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Lin, C.-Y. Juan, K.-J. Chang, W.-J. Chen, and M.-L. Kuo IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1 Carcinogenesis, December 1, 2001; 22(12): 1947 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, Y. Xu, L. M. Kamendulis, and J. E. Klaunig Morphological Transformation by 8-Hydroxy-2'-deoxyguanosine in Syrian Hamster Embryo (SHE) Cells Toxicol. Sci., August 1, 2000; 56(2): 303 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Smith, L. Zhang, M. Jeng, Y. Wang, W. Guo, P. Duramad, A. E. Hubbard, G. Hofstadler, and N. T. Holland Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells Carcinogenesis, August 1, 2000; 21(8): 1485 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Smith Benzene, NQO1, and genetic susceptibility to cancer PNAS, July 6, 1999; 96(14): 7624 - 7626. [Full Text] [PDF] |
||||
![]() |
M.-L. Kuo, S.-G. Shiah, C.-J. Wang, and S.-E. Chuang Suppression of Apoptosis by Bcl-2 to Enhance Benzene Metabolites-Induced Oxidative DNA Damage and Mutagenesis: A Possible Mechanism of Carcinogenesis Mol. Pharmacol., May 1, 1999; 55(5): 894 - 901. [Abstract] [Full Text] |
||||
![]() |
R. H. Schiestl, J. Aubrecht, F. Khogali, and N. Carls Carcinogens induce reversion of the mouse pink-eyed unstable mutation PNAS, April 29, 1997; 94(9): 4576 - 4581. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |